Aphria Inc (TSE:APHA)’s share price traded up 0.9% during trading on Friday . The company traded as high as C$5.99 and last traded at C$5.70, 4,104,576 shares were traded during mid-day trading. An increase of 12% from the average session volume of 3,671,520 shares. The stock had previously closed at C$5.65.

A number of equities research analysts have commented on the company. Alliance Global Partners reissued a “buy” rating and issued a C$11.00 price objective on shares of Aphria in a research note on Tuesday, January 21st. Jefferies Financial Group reduced their price objective on Aphria from C$11.00 to C$10.30 in a research note on Monday, January 20th. CIBC raised Aphria from an “underperform” rating to a “neutral” rating and raised their price objective for the company from C$6.50 to C$7.00 in a research note on Wednesday, January 15th. Finally, Pi Financial reduced their price objective on Aphria from C$9.00 to C$8.00 and set a “buy” rating for the company in a research note on Wednesday, January 15th.

The stock has a fifty day moving average of C$6.40 and a 200 day moving average of C$7.21. The firm has a market capitalization of $1.47 billion and a P/E ratio of -16.62. The company has a debt-to-equity ratio of 28.80, a current ratio of 5.43 and a quick ratio of 3.69.

About Aphria (TSE:APHA)

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

See Also: How is the discount rate different from the Federal Funds rate?

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.